Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine ; volume:17 ; number:1 ; day:24 ; month:5 ; year:2019 ; pages:1-18 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (24.5.2019), 1-18, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1924-1
- URN
-
urn:nbn:de:101:1-2019091903581492914522
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwerdtfeger, Melanie
- Andersson, Anne-Marie Carola
- Neukirch, Lasse
- Holst, Peter Johannes
- SpringerLink (Online service)
Ähnliche Objekte (12)
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
Designed virus-like particles as novel modular vaccine delivery system for synthetic peptide antigens
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
Evaluation of a replication-competent VSV-SIV vaccine candidate
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Virus-like structures for combination antigen protein mRNA vaccination
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches